The impact of empagliflozin on eGFR and albuminuria: results from the ABCD nationwide empagliflozin audit

TSJ Crabtree1,2,3, J Elliott4, A Bickerton5, A Evans6, S Phillips6, K Dhatariya7, I Gallen8, REJ Ryder1; on behalf of ABCD empagliflozin audit contributors9

 

1 Sandwell and West Birmingham Hospitals NHS Trust

2 University Hospitals of Derby and Burton NHS Trust

3 University of Nottingham

4. Sheffield Teaching Hospitals NHS Trust

5 Yeovil District Hospitals NHS Foundation Trust

6 Gloucestershire Hospitals NHS Trust

7 Norfolk and Norwich NHS Trust

8 Royal Berkshire NHS Foundation Trust

9 Association of British Clinical Diabetologists

PDF icon The impact of empagliflozin on eGFR and albuminuria: results from the ABCD nationwide empagliflozin audit
Discipline: 
Diabetes
Clinical taxonomy: 
Chronic kidney disease
Diabetic nephropathy
Treatments for diabetes
Resource taxonomy: 
Audit
Posters
6th Joint Meeting of ABCD & UKKA 2023

ABCD Webinar Series

ABCD Webinars